Evidence map›Paper›PMID 36840630›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2023

Malic Enzyme 1 as a Novel Anti-Ferroptotic Regulator in Hepatic Ischemia/Reperfusion Injury.

Xuexian Fang, Jiawei Zhang, You Li, Yijing Song, Yingying Yu, Zhaoxian Cai, Fuzhi Lian, Jun Yang, Junxia Min, Fudi Wang

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
23.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 87 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Ferroptosis: biology and role in liver disease.Journal of gastroenterology · 2025
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Xuexian FangDepartment of Nutrition and Toxicology, Key Laboratory of Elemene Class Anti-Cancer Chinese Medicines of Zhejiang Province, School of Public Health, Hangzhou Normal University, Hangzhou, 311121, China.ORCID 0000-0001-5414-9888
Jiawei ZhangDepartment of Nutrition and Toxicology, Key Laboratory of Elemene Class Anti-Cancer Chinese Medicines of Zhejiang Province, School of Public Health, Hangzhou Normal University, Hangzhou, 311121, China.
You LiDepartment of Nutrition and Toxicology, Key Laboratory of Elemene Class Anti-Cancer Chinese Medicines of Zhejiang Province, School of Public Health, Hangzhou Normal University, Hangzhou, 311121, China.
Yijing SongDepartment of Nutrition and Toxicology, Key Laboratory of Elemene Class Anti-Cancer Chinese Medicines of Zhejiang Province, School of Public Health, Hangzhou Normal University, Hangzhou, 311121, China.
Yingying YuThe Second Affiliated Hospital, The First Affiliated Hospital, School of Public Health, Institute of Translational Medicine, State Key Laboratory of Experimental Hematology, Zhejiang University School of Medicine, Hangzhou, 310058, China.
Zhaoxian CaiThe Second Affiliated Hospital, The First Affiliated Hospital, School of Public Health, Institute of Translational Medicine, State Key Laboratory of Experimental Hematology, Zhejiang University School of Medicine, Hangzhou, 310058, China.
Fuzhi LianDepartment of Nutrition and Toxicology, Key Laboratory of Elemene Class Anti-Cancer Chinese Medicines of Zhejiang Province, School of Public Health, Hangzhou Normal University, Hangzhou, 311121, China.ORCID 0000-0002-0733-579X
Jun YangDepartment of Nutrition and Toxicology, Key Laboratory of Elemene Class Anti-Cancer Chinese Medicines of Zhejiang Province, School of Public Health, Hangzhou Normal University, Hangzhou, 311121, China.
Junxia MinThe Second Affiliated Hospital, The First Affiliated Hospital, School of Public Health, Institute of Translational Medicine, State Key Laboratory of Experimental Hematology, Zhejiang University School of Medicine, Hangzhou, 310058, China.
Fudi WangThe Second Affiliated Hospital, The First Affiliated Hospital, School of Public Health, Institute of Translational Medicine, State Key Laboratory of Experimental Hematology, Zhejiang University School of Medicine, Hangzhou, 310058, China.ORCID 0000-0001-8730-0003
Hangzhou Normal University · CNSecond Affiliated Hospital of Zhejiang University · CNFirst Affiliated Hospital of University of South China · CN

Funding

National Key Research and Development Program of China 2018YFA0507801National Key Research and Development Program of China 2018YFA0507802National Natural Science Foundation of China 31930057National Natural Science Foundation of China 31970689National Natural Science Foundation of China 82170644Natural Science Foundation of Zhejiang Province LR23H020001Natural Science Foundation of Zhejiang Province LY22C110002
6 · The paper itself

Abstract

Ferroptosis has been linked to the pathogenesis of hepatic injury induced by ischemia/reperfusion (I/R). However, the mechanistic basis remains unclear. In this study, by using a mouse model of hepatic I/R injury, it is observed that glutathione (GSH) and cysteine depletion are associated with deficiency of the reducing power of nicotinamide adenine dinucleotide phosphate (NADPH). Genes involved in maintaining NADPH homeostasis are screened, and it is identified that I/R-induced hepatic ferroptosis is significantly associated with reduced expression and activity of NADP

Indexed as

LiverReperfusion InjuryGlutathioneHumansMalate DehydrogenaseNADPTOR Serine-Threonine KinasesGlutathioneMalate Dehydrogenasemalate dehydrogenase (decarboxylating)NADPTOR Serine-Threonine Kinasesferroptosishepatic ischemia/reperfusion injurymalatemalic enzyme 1nicotinamide adenine dinucleotide phosphate

Identifiers

PMID36840630
PMCPMC10161122
OpenAlexW4321851525

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.